During Wednesday’s Morning trade, Shares of Arena Pharmaceuticals, Inc. (NASDAQ:ARNA), gained 3.66% to $2.02.
Park Lane Advisor has initiated coverage on the following equities: Arena Pharmaceuticals Inc. (ARNA), Compugen Ltd (CGEN), ChemoCentryx Inc. (CCXI), and Concert Pharmaceuticals Inc. (CNCE). Free research report on Arena Pharma can be accessed at http://www.parklaneadvisor.com/ On Tuesday, December 22, 2015, the NASDAQ Composite ended at 5,001.11, up 0.65%, the Dow Jones Industrial Average advanced 0.96%, to finish the day at 17,417.27, and the S&P 500 closed at 2,038.97, up 0.88%. The gains were broad based as all the sectors ended the session in positive. Register for your complimentary reports at the links given below.
On Tuesday, shares in Arena Pharmaceuticals Inc. recorded a trading volume of 2.25 million shares, lower than their three months average volume of 3.43 million shares. The stock ended the day 3.94% lower at $1.95. Arena Pharmaceuticals Inc.’s stock has lost 6.25% in the last one month, 23.83% in the previous three months and 43.80% on YTD basis. The company is trading below its 50-day and 200-day moving averages by 4.83% and 42.77%, respectively. Furthermore, shares of Arena Pharmaceuticals Inc. have a Relative Strength Index (RSI) of 47.80.
Arena Pharmaceuticals, Inc., a biopharmaceutical company, discovers, develops, and commercializes novel drugs that target G protein-coupled receptors. The company offers BELVIQ, a drug used to treat chronic weight administration in adults.
Shares of Goldman Sachs Group Inc (NYSE:GS), inclined 0.71% to $ 181.55, during its current trading session.
Goldman Sachs Asset Administration declared further updates in its money market fund product line to prepare clients for the Securities and Exchange Commission’s (“SEC’s”) Rule 2a-7 amendments, which become effective in October 2016.
“We are committed to making sure our clients and partners understand the new requirements so they can make an informed decision on how best to proceed with their investments in 2016. We continue to engage with them on how to best support their evolving investment needs and will continue to make updates as needed,” said Dave Fishman, Managing Director and Co-Head of Global Liquidity Administration.
The Goldman Sachs Group, Inc. operates as an investment banking, securities, and investment administration company worldwide. The company operates through four segments: Investment Banking, Institutional Client Services, Investing & Lending, and Investment Administration.
Finally, H & R Block Inc (NYSE:HRB), gained 0.42%, and is now trading at $33.52.
H&R Block (HRB), declared two-time NBA All-Star Anthony Davis will serve as a brand ambassador for its forthcoming tax season.
H&R Block is the NBA’s tax services partner and will feature Davis alongside the brand’s bow-tie wearing tax pro Richard Gartland in its 2016 advertising. Davis will make a cameo in commercials startning mid-January, and then will star in spots set to air in February. This partnership marks the first time the brand has used a sports personality in a national campaign.
“We’re excited to partner with a dominant player like Anthony for Refund Season,” said Kathy Collins, H&R Block’s chief marketing officer. “We’re so impressed with his determination and commitment to the community. Anthony has a lot of qualities our clients can relate to — even if his first job out of college has far more complex tax implications than most of ours.”
H&R Block, Inc., through its auxiliaries, provides tax preparation, banking, and other services to the general public primarily in the United States, Canada, and Australia. The company offers assisted income tax return preparation and related services through a system of retail offices operated directly by the company or by franchisees; and online tax services, such as tax advice, professional and do-it-yourself (DIY) tax return preparation, and electronic filing services through its Website hrblock.com.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should/might occur.